Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lexeo Therapeutics, Inc. (LXEO) has issued an update.
Bernard Davitian has informed Lexeo Therapeutics, Inc. that he will not seek re-election at the upcoming annual stockholders’ meeting. This decision is not fueled by any disputes or disagreements over the company’s operational, policy, or practice matters.
See more data about LXEO stock on TipRanks’ Stock Analysis page.